Skip to main content
. Author manuscript; available in PMC: 2016 Oct 1.
Published in final edited form as: Eur Respir J. 2015 Jun 25;46(4):1193–1196. doi: 10.1183/09031936.00009415

TABLE 1.

Linear regression analyses of the association between age, current smoking and pulmonary function tests and parametric response mapping (PRM)

PRMfSAD PRMEmph PRMPD
Age years# 0.06** (0.04–0.08) 0.05** (0.03–0.06) 0.01* (0.00–0.01)
Current smoking −0.14 (−0.65−0.37) −0.42 (−0.89−0.05) 0.24* (0.03–0.44)
Pulmonary function tests+
 FEV1 L 0.18 (−0.47–0.83) 0.27 (−0.33–0.86) −0.17 (−0.43−0.09)
 FEV1/FVC % −0.06** (−0.12–−0.01) −0.05 (−0.10−0.00) 0.01 (−0.01–0.03)
 FEF25–75% L·s−1 −0.28 (−0.62−0.06) −0.19 (−0.50−0.13) 0.01 (−0.13–0.15)
 FEF25–75%/FVC s−1 −2.29* (−3.84−−0.75) −1.73** (−3.17−−0.29) 0.33 (−0.32–0.98)
 RV L 3.65** (0.19–7.11) 1.01 (−0.40–2.42) −0.44 (−4.72−3.83)
 TLC L 0.56** (0.12–0.99) 0.53** (0.13–0.93) −0.11 (−0.29−0.07)
 RV/TLC % 0.11* (0.04–0.17) 0.08** (0.01–0.14) 0.01 (−0.02–0.04)
TLCOc/VA mmol·min−1·kPa−1·L−1 −1.97** (−3.55−−0.39) −1.62** (−3.08−−0.16) 0.36 (−0.29–1.01)
R5R20 kPa·L−1·s−1 −6.59** (−12.2−−0.92) −4.84 (−10.11−0.43) 0.41 (−0.19–2.76)
X5 kPa·L−1·s−1 4.92 (−3.51–13.35) 5.02 (−2.72–12.76) −0.62 (−4.04−2.80)

Data are presented as β (95% CI). PRM values were normalised by natural-logarithmic transformation. PRMfSAD: extent of small airway disease; PRMEmph: extent of emphysema; PRMPD: extent of parenchymal disease; FEV1: forced expiratory volume 1 s; FVC: forced vital capacity; FEF25–75%: forced expiratory flow at 25–75% of FVC; RV: residual volume; TLC: total lung capacity; TLCOc: transfer factor of the lung for carbon monoxide correction for haemoglobin; VA: alveolar volume; R5: resistance at 5 Hz; R20: resistance at 20 Hz; X5: reactance at 5 Hz.

#

adjusted for sex and smoking status

adjusted for sex and age

+

adjusted for age, sex, smoking status and height. Bold indicates statistically significant values.

*

p<0.05

**

p<0.01.